The Prognostic Value of Chromosome 7 Polysomy in Non-small Cell Lung Cancer Patients Treated with GefitinibLela Buckingham, Philip Bonomi, Ann M. Mauer et al.|Journal of Thoracic Oncology|2007Cited by 40
Effects of <i>ERBB2</i> amplicon size and genomic alterations of chromosomes 1, 3, and 10 on patient response to trastuzumab in metastatic breast cancerLarry E. Morrison, John S. Coon, Susan Jewell et al.|Genes Chromosomes and Cancer|2007Cited by 26
Chromosome 7 polysomy and biomarker combinations as potential predictors of gefitinib efficacy in non-small cell lung cancer (NSCLC).John S. Coon, Philip Bonomi, Lela Buckingham et al.|Clinical Cancer Research|2006Cited by 0